Lab Automation Markets Worldwide (Next-Generation Systems, Key Companies, Forecasts and Trends)


August 1, 2008
150 Pages - SKU: KLI1670001
Attention: There is an updated edition available for this report.
License type:
Countries covered: Global

The benefits of automation in the clinical laboratory are well documented. They involve replacing manual, potentially dangerous, error-prone steps with automated processes requiring minimal operator intervention. This approach can increase productivity, decrease turnaround time, improve staff safety, minimize errors, improve the handling of specimens, and allow labs to reallocate personnel to more important and productive tasks.

For drug discovery, automation also offers benefits. bringing a new drug to market has been both a very time-intensive, laborious and expensive undertaking.

This report analyzes the current and potential world markets for medical laboratory automation systems and equipment - both for clinical diagnostics and drug discovery research laboratories.

These are some of the recent developments that are assessed in the report and considered in market projections:

  • Next-Generation vs. Traditional Systems

  • Labcyte and Allegro Combine Operations

  • Agilent Acquistion of Velocity

  • New Closed-Loop Smart Gripper

  • Tecan-VWR Alliance

  • New Sample Processing Platforms

  • High Throughput Flexibility

  • Robotics Research Lab Established

  • Hamilton Purchase of TekCel

  • Low Temperature Sample Storage

  • Automated Microplate Processing

Current Market and Forecasts to 2012 for the following segments are included:

  • Sample Transport Systems

  • Specimen Handling Systems

  • Storage and Retrieval Systems

  • Work stations

  • Plate Readers

  • Robotics

  • Dissolution Testing

  • Laboratory Information Management Systems (LIMS)
Revenues for clinical labs and drug discovery labs are broken out.

As a report with international focus, markets for North America, Europe and Asia are provided.

This report also reviews the nature and direction of research and trends, and gives insight into some issues facing the industry. The report profiles several companies involved in developing and marketing these systems. Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies.

The market data provide multiple year forecasts for different product segments covered in the report.

The information presented in this report is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives and researchers. Companies profiled in this report include:

  • Abbott Diagnostics
  • Agilent Technologies Inc.
  • Ai Scientific
  • Aurora Biotechnologies
  • Beckman Coulter Inc.
  • BioTrove Inc.
  • Caliper Life Sciences
  • Dynacon Inc.
  • Eppendorf AG
  • Hamilton Storage Technologies Inc.
  • InnovaSystems Inc.
  • Labotix Automation Inc.
  • LabVantage Solutions Inc.
  • Molecular Devices
  • Motoman Inc.
  • Olympus Corp.
  • PerkinElmer Life and Analytical Sciences Inc.
  • F. Hoffmann-La Roche Ltd.
  • RTS Group
  • Siemens Medical Solutions USA Inc.
  • Sotax
  • SSi Robotics
  • PaR Systems Inc.
  • The Automation Partnership
  • Tecan Group Ltd.
  • ThermoFischer Scientific Inc.
  • Xiril AG



More Drug Discovery reports by Kalorama Information

Lab Automation Markets, 3rd. Edition (Systems, Key Companies, Forecasts and Trends) by Kalorama Information
This report, Lab Automation Markets, 3rd Edition, (Systems, Key Companies, Forecasts and Trends), represents Kalorama Information's latest study of the market for systems that enable ...
The World Market for Implantable and Needle-Free Drug Delivery Systems by Kalorama Information
This report, The World Market for Implantable and Needle-Free Drug Delivery details the types of drug delivery systems and technologies that are being used in ...
The Next Wave In Cancer Treatment - Kinase Inhibitors by Kalorama Information
This Kalorama Information report – The Next Wave in Cancer Treatment--Kinase Inhibitors - is focused on a growing area of cancer treatment, kinase inhibitors. ...
Hospital Acquired Infections: Testing Markets by Kalorama Information
A nosocomial, or hospital-acquired, infection is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is ...
See all reports like this >>

More Global Drug Discovery reports

Inflammatory Pain Global Clinical Trials Review, H1, 2013 by GlobalData
Inflammatory Pain Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Inflammatory Pain Global Clinical Trials Review, H1, 2013 provides data on the Inflammatory Pain ...
Cancer Pain Global Clinical Trials Review, H1, 2013 by GlobalData
Cancer Pain Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Cancer Pain Global Clinical Trials Review, H1, 2013 provides data on the Cancer Pain ...
Ascites Global Clinical Trials Review, H1, 2013 by GlobalData
Ascites Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Ascites Global Clinical Trials Review, H1, 2013 provides data on the Ascites clinical trial scenario. ...
Radiculopathy Global Clinical Trials Review, H1, 2013 by GlobalData
Radiculopathy Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Radiculopathy Global Clinical Trials Review, H1, 2013 provides data on the Radiculopathy clinical trial scenario. ...
See all reports like this >>